PL2215480T3 - Narzędzia do diagnostyki i terapii chorób zmieniających funkcję naczyń - Google Patents

Narzędzia do diagnostyki i terapii chorób zmieniających funkcję naczyń

Info

Publication number
PL2215480T3
PL2215480T3 PL08855400T PL08855400T PL2215480T3 PL 2215480 T3 PL2215480 T3 PL 2215480T3 PL 08855400 T PL08855400 T PL 08855400T PL 08855400 T PL08855400 T PL 08855400T PL 2215480 T3 PL2215480 T3 PL 2215480T3
Authority
PL
Poland
Prior art keywords
diagnostic
diseases
therapeutic tools
vascular function
altering vascular
Prior art date
Application number
PL08855400T
Other languages
English (en)
Inventor
Hans Vink
Erik Sjoerd Gerard Stroes
Original Assignee
Univ Maastricht
Acad Ziekenhuis Maastricht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39247715&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2215480(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Maastricht, Acad Ziekenhuis Maastricht filed Critical Univ Maastricht
Publication of PL2215480T3 publication Critical patent/PL2215480T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/328—Vasculitis, i.e. inflammation of blood vessels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PL08855400T 2007-11-30 2008-12-01 Narzędzia do diagnostyki i terapii chorób zmieniających funkcję naczyń PL2215480T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07122043 2007-11-30
EP08855400A EP2215480B1 (en) 2007-11-30 2008-12-01 Diagnostic and therapeutic tools for diseases altering vascular function
PCT/EP2008/066524 WO2009068685A1 (en) 2007-11-30 2008-12-01 Diagnostic and therapeutic tools for diseases altering vascular function

Publications (1)

Publication Number Publication Date
PL2215480T3 true PL2215480T3 (pl) 2012-09-28

Family

ID=39247715

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08855400T PL2215480T3 (pl) 2007-11-30 2008-12-01 Narzędzia do diagnostyki i terapii chorób zmieniających funkcję naczyń

Country Status (12)

Country Link
US (1) US8759095B2 (pl)
EP (1) EP2215480B1 (pl)
JP (1) JP5597543B2 (pl)
CN (1) CN101918845B (pl)
AT (1) ATE554396T1 (pl)
BR (1) BRPI0821105A2 (pl)
CA (1) CA2706307C (pl)
DK (1) DK2215480T3 (pl)
ES (1) ES2386231T3 (pl)
PL (1) PL2215480T3 (pl)
PT (1) PT2215480E (pl)
WO (1) WO2009068685A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8759095B2 (en) 2007-11-30 2014-06-24 Universiteit Maastricht Diagnostic and therapeutic tools for diseases altering vascular function
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
US10070796B2 (en) 2015-02-04 2018-09-11 General Electric Company Systems and methods for quantitative microcirculation state monitoring
CA3020277C (en) 2015-04-08 2026-07-21 Microvascular Health Solutions, LLC Synergistic glycocalyx treatment compositions and methods
WO2016176089A1 (en) 2015-04-29 2016-11-03 Kardiatonos, Inc. Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage
US10507253B2 (en) 2016-03-17 2019-12-17 Paul C. Lee Nanoparticle probes and methods of making and use thereof
US10507252B2 (en) 2016-03-17 2019-12-17 Paul C. Lee Nanoparticle probes and methods of making and use thereof
WO2018208846A1 (en) * 2017-05-08 2018-11-15 Microvascular Health Solutions, LLC Compositions, systems, and methods for assessing and improving vascular health and treatments involving the same
CN107271348B (zh) * 2017-07-06 2019-11-15 苏州大学 一种医用人造管道渗透性能测试系统及其使用方法
US11994519B2 (en) * 2017-12-13 2024-05-28 Glx Analytix Aps Biomarkers for multiple sclerosis
CN108681510A (zh) * 2018-05-21 2018-10-19 迈克医疗电子有限公司 数据处理方法及装置
EP3623816A1 (en) 2018-09-12 2020-03-18 GLX Analytix ApS Glx-derived molecule detection
FI3666883T3 (fi) * 2018-12-12 2025-05-13 Zhongke Xinray Suzhou Biological Tech Co Limited Menetelmä endoteelin glykokalyksiin liittyviä sairauksia vastaan ennaltaehkäisevän ja terapeuttisen vaikutuksen omaavien yhdisteiden seulomiseksi
WO2021062298A1 (en) 2019-09-27 2021-04-01 Arterez, Inc. Biomarker panel targeted to diseases due to multifactorial ontology of glycocalyx disruption
US11852577B2 (en) * 2021-09-29 2023-12-26 Orange Biomed Ltd., Co. Apparatus for measuring properties of particles in a solution and related methods
EP4630783A1 (en) 2022-12-09 2025-10-15 Orange Biomed Co., Ltd. Sample-testing system for measuring properties of red blood cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
JP3566756B2 (ja) * 1993-09-03 2004-09-15 謙 石原 非侵襲血液分析装置とその方法
JP2003510112A (ja) 1999-09-23 2003-03-18 ジー.ナドウ リチャード 直交偏光スペクトルイメージングの医学的応用
EP1501565B1 (de) * 2002-05-09 2006-11-02 Hemoteq GmbH Verbindungen und verfahren zur hemokompatiblen beschichtung von oberflächen
US7497940B2 (en) 2003-09-02 2009-03-03 Koji Sode Glucose sensor and glucose level measuring apparatus
EP1751509A1 (en) 2004-05-14 2007-02-14 Koninklijke Philips Electronics N.V. Fiber optic probe
JP2007054483A (ja) 2005-08-26 2007-03-08 Olympus Corp 装着型顕微鏡システム
WO2007075388A2 (en) 2005-12-15 2007-07-05 X-Cell Medical Incorporated Methods of locally treating and preventing cardiac disorders
US8759095B2 (en) 2007-11-30 2014-06-24 Universiteit Maastricht Diagnostic and therapeutic tools for diseases altering vascular function

Also Published As

Publication number Publication date
US20100304424A1 (en) 2010-12-02
DK2215480T3 (da) 2012-07-30
US8759095B2 (en) 2014-06-24
BRPI0821105A2 (pt) 2015-10-06
EP2215480B1 (en) 2012-04-18
CA2706307A1 (en) 2009-06-04
JP2011507560A (ja) 2011-03-10
CN101918845A (zh) 2010-12-15
EP2215480A1 (en) 2010-08-11
JP5597543B2 (ja) 2014-10-01
WO2009068685A1 (en) 2009-06-04
ATE554396T1 (de) 2012-05-15
CA2706307C (en) 2017-01-17
CN101918845B (zh) 2014-01-29
PT2215480E (pt) 2012-07-18
ES2386231T3 (es) 2012-08-14

Similar Documents

Publication Publication Date Title
ATE554396T1 (de) Diagnose- und therapiewerkzeuge für krankheiten, die die gefässfunktion verändern
CY1121327T1 (el) Τροποποιημενα αντισωματα anti-il-23p19
PH12021550756A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
MX2013001362A (es) Inmunoglubinas de dominio variable doble y usos de las mismas.
EA201101520A1 (ru) Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
UA104459C2 (uk) Антитіла проти fgfr3 і способи їх застосування
ECSP11011496A (es) Inmunoglobulinas de dominio variable dual y usos de las mismas
AU324652S (en) Vehicle
PH12013500310B1 (en) Activin-actrii antagonists and uses for increasing red blood cell levels
GB0515353D0 (en) Food
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
AU329027S (en) Diagnostic device
AU324636S (en) Dishes
BRPI1015967A2 (pt) "unidade de dobradiça, e, peça de mobília."
MY156667A (en) Disubstituted phthalazine hedgehog pathway antagonists
AU323419S (en) Teething device
FR2924118B1 (fr) Fragments d'anticorps inhibiteurs de la proteine nef du vih.
WO2009102438A3 (en) Aptamer inhibitors of osteopontin and methods of use thereof
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
NO20091386L (no) Fenyloksyanilinderivater
DK2250190T3 (da) Optimerede adhæsinfragmenter og tilsvarende nanopartikler,
GB0508988D0 (en) Organic compounds
TR201102540U (tr) Hidrolik ayaklı yaşam konteyneri.
WO2010132708A3 (en) Modulation of terminase activity at telomeres and dna double-strand breaks